In short
Midjourney’s surprise move into medical imaging is attracting attention, but radiologists say the company has not shown enough evidence to support its bold claims. Experts question whether the water-based scanner can match MRI-like performance or safely deliver meaningful health benefits.
- Experts say Midjourney has not provided enough evidence for its medical imaging claims.
- The startup’s water-based ultrasound scanner faces major physics and usability challenges.
- Critics worry the wellness framing could confuse consumers and displace proven screenings.
- Midjourney says it is starting in wellness, with future medical use subject to regulation and testing.
Midjourney, the company that built its reputation on generating striking images with AI, is now trying to sell a very different vision: a body scanner that would place users in a water-filled tank and produce detailed internal images in under a minute. The startup says the device could eventually deliver scans comparable to MRI, while feeling more like a spa treatment than a hospital appointment. Radiologists and imaging researchers, however, say the pitch is far ahead of the evidence.
The company’s announcement has sparked both fascination and skepticism because it lands in one of the most sensitive corners of technology: medical imaging. Midjourney is not just talking about a new gadget. It is proposing a future in which people regularly undergo body scans for wellness, body composition tracking and possibly, one day, broader screening. Experts contacted about the plan say that vision is not impossible in principle, but the public case for it remains thin, the technical hurdles are substantial, and the clinical value has not been shown.
That tension sits at the center of the debate. Midjourney is presenting an ambitious product roadmap and a vision of more frequent imaging as a path to longer, healthier lives. Critics are asking for a far more basic deliverable: proof that the system works as claimed, proof that the images are useful, and proof that the company can avoid nudging people away from established medical tests.
What Midjourney says it is building
Midjourney’s proposed scanner is unlike a conventional imaging machine. According to the company’s description, a user would stand on a platform and descend into a vat of water while an array of underwater sensors and scanners fires sound waves through the body and records the echoes that return. The company has compared the process to dolphin echolocation and says a scan should take no longer than a minute.
The startup argues that the resulting images could provide a rich map of body composition and internal structure. In its public materials, the company describes a future in which these scans are embedded in spa-like settings, where a medical-looking procedure becomes a casual part of a luxury wellness visit. The visual branding is deliberate: golden rooms, tranquil water and a polished environment that looks much closer to a boutique retreat than a clinic.
Midjourney is careful, at least for now, to avoid presenting the scanner as a fully cleared diagnostic device. Instead, it frames the product as a wellness tool that can offer users more information about their bodies. The company says it wants to eventually expand into medical use, but that would require the kind of regulatory review and evidence base demanded of clinical devices.
Why the move surprised the medical world
For an AI company known primarily for generating art and stylized imagery, the shift into health technology is unusual. It is also strategically significant. Medical imaging is tightly regulated, technically demanding and ethically loaded. A consumer-facing AI product can move fast; a scanner meant to help people make health decisions must clear a much higher bar.
That is why the announcement landed with a mix of curiosity and alarm among imaging specialists. Several experts said the underlying idea is not absurd. Ultrasound has been used in medicine for decades, and researchers have been exploring broader-body scanning approaches for years. But the experts emphasized that Midjourney has offered little public evidence to show that its design can produce high-quality, clinically meaningful images at scale.
In other words, the company is asking people to imagine a future that may be plausible in broad terms, while offering only limited demonstration that its own version of that future is close at hand.
The central issue: where is the evidence?
The biggest criticism from radiologists and imaging scientists is not that the concept is impossible, but that the public case for it is underdeveloped. Midjourney has made bold comparisons to MRI, talked about broader health benefits and suggested that frequent scans could save lives. Yet experts say the company has not shown enough to support those claims.
That concern cuts across nearly every part of the pitch: the quality of the images, the speed of the scan, the claim that the device could rival MRI in practical use, and the suggestion that frequent body imaging could meaningfully reduce disease burden.
Several researchers pointed out that there is a difference between a clever prototype and a system that can be used responsibly by consumers. A prototype may demonstrate technical novelty. A useful medical tool must also prove repeatability, reliability, interpretability and patient benefit.
“There is a long road ahead to generating high-quality images and then to understand the clinical value and demonstrate net benefit to patients,” one imaging expert said in essence, stressing that the leap from concept to medical utility remains large.
How the scanner is supposed to work
Midjourney’s design centers on ultrasound, an established imaging method that uses sound waves rather than ionizing radiation. The company says its system would place the user in water because water can help transmit sound efficiently. The scanner would then collect returning echoes to form a three-dimensional body map.
That approach is important because it avoids one of the major downsides of CT scanning: radiation exposure. It also avoids the cramped, noisy environment associated with MRI. Midjourney’s pitch is that its system would be faster, more comfortable and, at least in principle, safe enough to use regularly.
But while the general concept has a real scientific basis, the practical execution is far from trivial. Ultrasound image quality depends heavily on how sound propagates through tissue, and that propagation is not easy to control across the whole body. Air, bone and body composition all affect the result. Those limits are well understood in medicine, which is why ultrasound is often used selectively and with a technician’s help rather than as a universal full-body replacement for other modalities.
Why water matters
Using a water bath is meant to create a better acoustic environment, but it introduces its own problems. Experts noted that the water would need to be exceptionally clean and bubble-free to support high-quality imaging. Even small imperfections can disrupt sound transmission.
That means the system is not just a scanner. It is also a controlled environment that would have to be maintained carefully between users. That raises practical questions about cost, sanitation, turnaround time and whether the device can be deployed at scale outside highly managed settings.
Why body size matters
Researchers also flagged body size as a major limitation. Ultrasound waves attenuate as they move through tissue, and that effect can become more pronounced when they must travel through larger or denser bodies. That is not a minor technical detail. It affects who gets useful images and who does not.
Midjourney has said it is working with partners to address the issue, but experts want to see evidence, not assurances. Imaging systems are judged not only by what they can show in ideal cases, but by how consistently they work across diverse patients.
What experts think is plausible
Not all the feedback has been dismissive. Some specialists say the project could have real potential if the company stays honest about what it can and cannot do.
Venkatesh Murthy, a professor of preventive cardiology, internal medicine and radiology at the University of Michigan Medical School, said the concept is interesting and that the field has long been exploring ways to improve body imaging. He described the underlying technology as promising, but said the company’s public claims about resolution and MRI-like performance go too far without validation.
Murthy also said some version of body composition analysis seems realistic. But he stressed that body composition is a much narrower goal than the more dramatic health and longevity claims attached to the product. In his view, the company’s marketing appears to blur the line between a useful wellness metric and a much broader medical promise.
“Body composition is plausible,” Murthy said, but he added that much of the surrounding message is about cancer screening, lifespan extension and overall health transformation rather than simply measuring fat, muscle and related markers.
Mark Anastasio, a professor of imaging sciences at Washington University in St. Louis, struck a similar note. He described the announcement as exciting and said the approach is not impossible. Researchers have been developing related whole-body imaging ideas for some time, he noted. But he emphasized that no public evidence yet shows the Midjourney system can compete with MRI in any meaningful way.
Matthew Davenport, a radiology professor at the University of Michigan Medical School, was more pointed. He said the company’s images are interesting, but the scale of the claims is far beyond what has been demonstrated. In his view, the pitch is one of the most expansive he has encountered in this space.
Why MRI comparisons are drawing pushback
Midjourney has repeatedly invited comparison to MRI, which is one reason the response from experts has been so sharp. MRI is one of the most capable imaging tools in medicine, but it is also expensive, slow and often uncomfortable. It uses powerful magnets and radio waves to create detailed pictures of organs and soft tissue.
Ultrasound, by contrast, is cheaper and more accessible, but it has known limitations. It cannot always see through air-filled structures well. Bone can block sound waves. Some organs are difficult to image unless a probe is positioned carefully. That is why ultrasound often depends on a trained operator working with a focused target rather than a fully automated full-body scan.
Scott Reeder, a professor at the University of Wisconsin School of Medicine and Public Health, said the idea is innovative but still unproven. He noted that MRI and CT answer different clinical questions and are not interchangeable. Any claim that a new ultrasound device is effectively equivalent to those systems, he said, would need rigorous validation.
Reeder also pointed out that some areas of the body are especially challenging for ultrasound, including the pelvis, the gut and regions obscured by bone or air. He questioned whether the company’s approach could overcome those barriers without sacrificing image quality.
CT, MRI and ultrasound: a quick comparison
| Modality | How it works | Strengths | Key limitations |
|---|---|---|---|
| Ultrasound | Sound waves and returning echoes | No ionizing radiation; relatively inexpensive; portable | Blocked by air and bone; highly dependent on technique and anatomy |
| CT | X-rays from multiple angles | Fast; excellent for bone and lungs; widely used in emergencies | Uses ionizing radiation; repeated scans raise exposure concerns |
| MRI | Magnets and radio waves | Detailed soft-tissue imaging; no ionizing radiation | Expensive; slow; can be uncomfortable or claustrophobic |
The wellness framing is doing a lot of work
One reason the announcement has raised eyebrows is that Midjourney appears to be leaning on the wellness category rather than immediately entering the medical device market. That distinction matters. A wellness product can often move with fewer regulatory obligations than a diagnostic tool, especially if the company avoids explicit disease detection claims.
By positioning the scanner as a general body-information device, Midjourney can suggest a future of preventive medicine while staying, for now, in a lighter regulatory lane. Critics say that makes the messaging unusually slippery. The product is presented with the language of clinical transformation, but sold through the logic of spa culture.
That blend is not new in health technology. Many companies use wellness language to market products that imply medical benefits without saying so directly. The problem, experts say, is that consumers may not understand the difference between a body composition map and a medically validated screening test.
That confusion could matter if people begin using a scanner like this in place of established exams. A person who assumes a body scan rules out cancer, for example, may skip a mammogram, colonoscopy or other recommended test. Radiologists worry that the promise of an easy, luxurious alternative could reduce adherence to proven screening practices.
What the company is promising for the future
Midjourney’s plan does not stop at a first-generation scanner. The company has already laid out a roadmap that extends several years into the future. According to its public vision, later versions of the system are expected to improve image quality, expand use cases and, eventually, move closer to more serious medical applications in partnership with regulators and clinicians.
The timeline is ambitious. The company says a first spa location could open in San Francisco in 2027. It also envisions a third-generation scanner arriving in 2028, at which point it expects the technology to become significantly more capable. By 2031, the company says it wants to have more than 50,000 scanners around the world and enough capacity to provide monthly scans to a billion people.
Those projections are striking not only for their scale, but for how quickly they presume adoption. They imply a future in which body scanning becomes routine, normalized and embedded in consumer health behavior on a massive global level.
That may be the dream. The question is whether the science, economics and regulation can keep pace.
Key milestones in Midjourney’s proposed rollout
| Year | Planned milestone | Why it matters |
|---|---|---|
| 2026 | Public debut of the scanner concept | Initial reaction from experts centers on evidence and feasibility |
| 2027 | First spa location in San Francisco | Signals a wellness-first commercial strategy |
| 2028 | Third-generation scanner | Midjourney says image quality and scan times should improve dramatically |
| 2031 | More than 50,000 scanners worldwide | Company claims this could support monthly scans for a billion people |
Why the regulatory questions matter
Midjourney says it has kept its first release within a general wellness framework and that it has confirmed this classification with the Food and Drug Administration. It also says it plans to submit regular test results to the agency as it explores expanded use cases.
That approach creates room to move quickly, but it also creates a challenge: the company may be encouraging expectations that are more medical than its current classification allows. If the device is not being marketed as a diagnostic tool, then it should not be treated like one. Yet the company’s broader messaging appears designed to invite exactly that assumption.
Experts say that is where the ethical risk lies. A product can be technically clever and still be dangerous if consumers misunderstand what it can do. The danger is not just false reassurance. It is the possibility that people will pay for a scan because they think it replaces more established care.
As one radiologist put it, it would be worrying if patients started replacing proven screening exams with a technology that has not yet shown it can do the same job.
That concern becomes even sharper when the product is packaged as part of a luxury wellness experience. People may be less likely to question the claims if the setting feels premium, the branding feels futuristic and the marketing language sounds scientific.
The physics problem no amount of branding can solve
Some of the harshest criticism of Midjourney’s scanner comes down to basic physics. Sound waves are useful, but they are not magic. They travel differently through fat, muscle, air and bone. They can lose strength over distance. They can be scattered or distorted. No amount of marketing can eliminate those limits.
That is why experts have questioned whether the company’s most dramatic comparisons are realistic. The idea that a water-based ultrasound system could be casually treated as an MRI substitute is a high bar. MRI produces deep, detailed images for a reason: the technology is built around a fundamentally different physical principle.
William Morrison, a radiology professor at Thomas Jefferson University, was among the most skeptical of the group. He argued that the water-bath concept reflects an older approach that has largely fallen out of favor because of those inherent sound-wave constraints. He also questioned whether the setup would be practical for ordinary use.
In his view, the scanner looks less like a medical breakthrough and more like an attention-grabbing product pitch. That assessment may sound severe, but it reflects a broader concern in the medical AI world: companies often use futuristic language to suggest they are solving hard health problems before the evidence is in hand.
The broader pattern in AI health marketing
Midjourney’s announcement fits a familiar pattern in artificial intelligence and health care. Startups often describe tools in broad, optimistic terms first and reserve the hard part — validation — for later. That strategy can work in consumer software. It is far more dangerous in medicine, where the gap between promise and evidence can affect real patients.
In recent years, many AI health products have leaned on terms like “clinical-grade” or “personalized” to imply legitimacy without necessarily proving clinical usefulness. Experts say those phrases can obscure the difference between something that looks impressive and something that changes outcomes.
That is why the burden of proof matters so much here. A company selling convenience or entertainment can survive on aesthetics and novelty. A company implying health benefits must show that its product improves outcomes, avoids harm and performs reliably in the real world.
Midjourney’s challenge is that its brand carries enormous cultural weight. Because people already associate the company with sophisticated AI image generation, its claims may receive more attention than those of a lesser-known hardware startup. That makes scrutiny even more important.
What would actually convince skeptics
Experts say Midjourney would need much more than renderings and optimistic blog posts to persuade the medical community. The company would need data showing image quality, reproducibility, comparison with existing modalities, performance across different body types and, ultimately, clinical benefit.
That could include studies demonstrating how well the scanner identifies specific conditions, how often it produces usable images, how it compares to standard screening or diagnostic pathways, and whether the scans lead to better decisions or outcomes.
It would also need to show that the product can work beyond idealized demo cases. The real test of any medical device is not what it can do for a narrow group of users in a highly controlled environment, but how it behaves in the messy world of routine care.
Until then, experts say, the safest interpretation is that Midjourney has described a concept with some scientific grounding, not a validated medical breakthrough.
Why the story matters beyond one startup
This debate is about more than Midjourney. It reflects a larger question facing the AI industry: how far can companies go in promising health benefits before they have delivered the evidence to justify them?
The answer matters because health technology has a history of seductive overreach. Bold promises can attract funding, users and media attention. They can also create false confidence. In medicine, that confidence can be expensive, emotionally charged and sometimes harmful.
Midjourney’s scanner may eventually prove useful in a limited or expanded form. It may also remain an intriguing concept whose best use is narrower than the company’s grandest messaging suggests. At this stage, no one outside the company appears ready to call it a transformed medical paradigm.
What experts are asking for is not cynicism. It is proof.
And in a field where images can be dazzling and claims can outpace reality, that remains the most important test of all.
Bottom line
Midjourney’s move into body scanning has generated enormous buzz because it sits at the intersection of AI, health and consumer wellness. But the technical idea still faces major hurdles, and specialists say the public evidence is not yet strong enough to support the company’s grandest claims. Until the startup can show that its scanner produces reliable, clinically meaningful results, skepticism is likely to remain the dominant reaction.
